Diseases · Entity Annotation Prototype (beta)

17articles mentioning diseases

25disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: prostate ×

prostate

This disease is selected. Its supporting articles are shown below.

Prostate17

Articles mentioning prostate

17 articles · page 2 of 2

264 Next-generation off-the-shelf CAR T cell targeting pan-tumor antigen MICA/B and engineered with immune evasion enables treatment across solid tumors without the need for conditioning chemotherapy

jitc · abstract · 2025-11-04 · 1 matching annotations

85.3%

solid tumors prostate cervical cancers FT836 mAb

…ed healthcare. The limited effectiveness of CAR T cells against solid tumors, combined with toxicity from CCT, highlights the urgent need fo…

625 Docetaxel enhances the anti-tumor activity of a novel bi-functional TCR activating molecule in breast and prostate cancer models

jitc · abstract · 2025-11-04 · 1 matching annotations

85.3%

4T1 TRAMP-C2 breast cancer prostate docetaxel

…lone showing an increased efficacy in cold tumor models such as 4T1 and TRAMP-C2. This data provides groundwork for the clinical de…

949 In vitro and in vivo efficacy of the antibody-drug-conjugate (ADC) PB-vcMMAE-5 against human carcinoma expressing truncated core 2 O-glycans

jitc · abstract · 2025-11-04 · 1 matching annotations

83.2%

triple negative breast prostate squamous non-small cell lung PB-vcMMAE-5 PB-vc-MMAE-5 PB-223 NEO-102

…in 9 human cancer cell lines, including prostate (PC-3, LnCAP), triple negative breast (HCC1937, MDA-MB-231), ER+,PR+,HER2+ breast (BT474), squamous n…

Multicancer early detection in a cohort of patients with confirmed and suspected cancer by measuring plasma amino acid cross sections with the Enlighten test: MODERNISED protocol

bmjopen · abstract · 2025-11-04 · 1 matching annotations

75.5%

melanoma cancer breast

…of origin (ToO) will include bladder, breast, colorectal, lung, melanoma, oesophageal, ovarian, pancreatic, prostate and renal. Particip…

Understanding characteristics of contemporary cancer survival for modelling the cost-effectiveness of new interventions

bmjonc · full text · 2025-10-15 · 1 matching annotations

87.2%

melanoma prostate thyroid cancers cancer SEER cancer drugs FDA

…tion). Meanwhile, the 5- year RSR of localised breast (female), melanoma, prostate and thyroid cancers all exceeded 99%.7 Similar statis…

Browse diseases

prostate

Articles mentioning prostate

264 Next-generation off-the-shelf CAR T cell targeting pan-tumor antigen MICA/B and engineered with immune evasion enables treatment across solid tumors without the need for conditioning chemotherapy

625 Docetaxel enhances the anti-tumor activity of a novel bi-functional TCR activating molecule in breast and prostate cancer models

949 In vitro and in vivo efficacy of the antibody-drug-conjugate (ADC) PB-vcMMAE-5 against human carcinoma expressing truncated core 2 O-glycans

Multicancer early detection in a cohort of patients with confirmed and suspected cancer by measuring plasma amino acid cross sections with the Enlighten test: MODERNISED protocol

Understanding characteristics of contemporary cancer survival for modelling the cost-effectiveness of new interventions